Are you a student (undergrad or grad) looking for policy experience? The NIH Office of Science Policy Summer internship program is now accepting applications: osp.od.nih.gov/the-2024-nih-o…

In case you missed it, our Founder and CEO Laura Kleiman recently published an Op-Ed in the The Boston Globe about the market failure for generic #drugrepurposing. The article is now available on our blog: rebootrx.org/blog/boston-gl…. #cancer

.Reboot Rx is #hiring for several roles across biomedical and clinical research, go-to-market strategy, and partnerships - starting with this remote Biomedical Scientist position. Please reach out if you might be a good fit, and help spread the word! linkedin.com/jobs/view/3925…

AI is changing health care. I loved exploring how with Nick Cain from @PJMFnd where we unpack how nonprofits like Intelehealth Jacaranda Health Reboot Rx leverage AI for better health outcomes ssir.org/articles/entry…

🌟 An inspiring DRK Foundation retreat with incredible entrepreneurs tackling global challenges. Grateful for the time together discussing leadership in uncertain times and achieving impact at scale. #Entrepreneurship #RebootRx #TheSolutionMayAlreadyExist Reboot Rx

🚀 Big news! We are proud to announce the publication of our latest paper in Frontiers - Pharmacology and Toxicology. We examine how new indications for generic drugs become the standard of care in #cancer and discuss case studies. 🔗 frontiersin.org/journals/pharm… #DrugRepurposing #TheSolutionMayAlreadyExist

#ScienceFridays 🔬 How can non-manufacturers in the U.S. advance drug repurposing for cancer? Find out in this week's paper, selected via our #DrugRepurposing Research Collection on ScienceOpen ➡ scienceopen.com/document?vid=e… ✍️ By researchers from Reboot Rx / Laura Kleiman

Happy Holidays from the Reboot Rx team! As we wrap up the year, we are grateful for our team’s growth and the strides we’ve made in advancing affordable cancer treatments. We’re excited to continue taking meaningful steps toward delivering high-quality cancer care for patients.

#MeetTheTeam - Meet Sara Church, our new Chief Operating Officer at Reboot Rx! Sara has 20+ years of experience and has held leadership roles at Sana Biotechnology, Eli Lilly, Amgen, and BMS. We are excited to have her join us! Learn more: rebootrx.org/church. #cancer #AI

🚀 We’re Hiring! Reboot Rx is seeking a Head/VP of Commercialization and Patient Impact to lead the charge in launching accessible and affordable #cancer treatments that improve the standard of care for patients. Help us spread the word. linkedin.com/jobs/view/4118…

💡 Check out our policy memo published by Federation of American Scientists🔬! We propose a dedicated regulatory pathway for non-manufacturers to seek FDA approval of new indications for repurposed generic drugs. Thank you to Arnold Ventures for funding. 👉 fas.org/publication/cl… #DayOne2025

🚀 We are hiring a Manager of Business Operations! This role will support our internal organizational processes and team as we develop affordable cancer treatments. linkedin.com/jobs/view/4126… #cancer #healthcare #patientimpact #operations #nonprofit #startups #hiring #jobs

Thank you to Boston 25 News & Kelly Sullivan for featuring Reboot Rx & Laura Kleiman! The segment highlights our work advancing affordable, evidence-based #cancer treatments and how it could be a game changer. Watch: boston25news.com/news/local/its… DRK Foundation #TheSolutionMayAlreadyExist

We are proud supporters of Reboot Rx, which uses AI technology to fast-track the development of affordable cancer treatments through repurposed generic drugs. Founder and CEO Laura Kleiman was featured in the Boston News: watch the segment to learn more about how Laura and her

Glad to join the Data-Driven #DrugRepurposing panel at the MIT Sloan School of Management Healthcare Conference to discuss how repurposing will reshape the clinical landscape over the next 10 years. And great to catch up with former Reboot Rx team member Gloria Wu! #TheSolutionMayAlreadyExist

Join our CEO Laura Kleiman at #ASPET2025 for Friday’s keynote on how AI + repurposed generic drugs are unlocking access to cancer care! 📅 April 4 | ⏰ 9–10 AM PDT #PatientImpact #DrugRepurposing #CancerResearch #Innovation #SocialImpact #RebootRx #TheSolutionMayAlreadyExist

#MeetTheTeam - Meet Kathleen Berryman, our new Manager of Business Operations at Reboot Rx! With 15+ years of nonprofit & for-profit business ops experience, we're excited to have her on the team! Learn more: rebootrx.org/berryman. #PatientImpact #TheSolutionMayAlreadyExist

Excited to connect with colleagues at #iDR25 next week in Amsterdam! If you’re working on generic #drugrepurposing and think a regulatory approval pathway could help, please reach out. Agenda: remedi4all.org/2025-internati… Reboot Rx REMEDi4ALL Beacon for Rare Diseases #TheSolutionMayAlreadyExist

At #iDR25, our CEO Laura Kleiman joined leaders from Anticancer Fund, Cures Within Reach, King's College London, @AmsterdamUMC, & @LUMC_leiden to discuss new efforts to expand patient access to repurposed generic drugs. #TheSolutionMayAlreadyExist #DrugRepurposing

Another fantastic #PrevConf25 conference with Cancer Research UK, American Cancer Society, & National Cancer Institute! Energizing discussions on repurposing generics for #cancerprevention and early interception. Highlight: connecting with Sir John Burns about the Sir John Burn trial results. #TheSolutionMayAlreadyExist